Internal Medicine, Medical Oncology · Kissimmee, FL
NPI
1770143752
Since 2019
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
737 W Oak St Ste 100
Kissimmee, FL, 34741
Phone (407) 933-2775
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
3,393 services
Medicare patients, 2024
112
Average age 75
Drug cost, 2024
$1.8M
694 prescriptions
Company payments, 2025
$17.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raul Vera-Gimon was code 99214 (office e&m - established), 177 times for 81 patients. In total Raul Vera-Gimon billed 3,393 services in 54 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 177 | 81 | $99.09 | $18K |
| 85025 Blood Count | Office | 64 | 32 | $7.61 | $487 |
| 36415 Venipuncture Blood Collection | Office | 55 | 33 | $8.65 | $476 |
| 99204 Office E&M - New | Office | 28 | 28 | $109.97 | $3,079 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $123.06 | $1,600 |
| 99215 Office E&M - Established | Office | 12 | 12 | $138.84 | $1,666 |
By year: 2023 $19K for 881 services; 2024 $41K for 3,393 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 64 | 32 | $7.61 | $487 |
| 36415 Venipuncture Blood Collection | 55 | 33 | $8.65 | $476 |
Medicare prescription drug claims, 2024
In 2024, the drug Raul Vera-Gimon prescribed most often to Medicare patients was Anastrozole, with 75 prescriptions and refills. In total Raul Vera-Gimon wrote 694 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 75 | 135 | 22 | $1,419 |
| Letrozole Generic | 45 | 59 | 13 | $523 |
| Hydroxyurea Generic | 33 | 46 | Under 11 | $626 |
| Kanjinti Trastuzumab-Anns | 31 | 31 | Under 11 | $129K |
| Imatinib Mesylate Generic | 25 | 25 | Under 11 | $66K |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 22 | 49 | 13 | $239 |
| Retacrit Epoetin Alfa-Epbx | 20 | 20 | Under 11 | $17K |
| Dexamethasone Generic | 20 | 22 | Under 11 | $375 |
| Pantoprazole Sodium Generic | 19 | 29 | 11 | $170 |
| Ondansetron Odt Ondansetron | 19 | 20 | Under 11 | $597 |
| Procrit Epoetin Alfa | 16 | 16 | Under 11 | $48K |
| Perjeta Pertuzumab | 15 | 15 | Under 11 | $96K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 15 | 15 | Under 11 | $388 |
| Ibrance Palbociclib | 15 | 15 | Under 11 | $268K |
| Herceptin Trastuzumab | 15 | 15 | Under 11 | $57K |
Brand drugs: 225 claims; generic drugs: 469 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raul Vera-Gimon $17.85 ($17.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Incyte Corporation with $17.85.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $17.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.